290 related articles for article (PubMed ID: 29683282)
21. Photodynamic therapy and plaque phase mycosis fungoides.
Fernández-Guarino M; Jaén P
G Ital Dermatol Venereol; 2011 Dec; 146(6):457-61. PubMed ID: 22095177
[TBL] [Abstract][Full Text] [Related]
22. Terapêutica Fotodinâmica com metil-aminolevulinato no tratamento de lesões refractárias de Micose Fungóide: resposta clínica e histológica mantida em dois doentes.
Teixeira AI; Maia E Silva J
Dermatol Online J; 2016 Sep; 22(9):. PubMed ID: 28329611
[TBL] [Abstract][Full Text] [Related]
23. Skin directed therapy for mycosis fungoides: a review.
Berthelot C; Rivera A; Duvic M
J Drugs Dermatol; 2008 Jul; 7(7):655-66. PubMed ID: 18664158
[TBL] [Abstract][Full Text] [Related]
24. Photodynamic therapy with intradermal application of 5-aminolevulinic acid successfully improved tumor lesions of mycosis fungoides.
Kabata Y; Shimomura Y; Matsuo Y; Fujiwara H; Abe R
Int J Dermatol; 2017 Apr; 56(4):e81-e82. PubMed ID: 28133722
[No Abstract] [Full Text] [Related]
25. The treatment of unilesional mycosis fungoides with methyl aminolevulinate-photodynamic therapy.
Hegyi J; Frey T; Arenberger P
J Eur Acad Dermatol Venereol; 2008 Sep; 22(9):1134-5. PubMed ID: 18266688
[No Abstract] [Full Text] [Related]
26. Photodynamic therapy in mycosis fungoides.
Fernández-Guarino M; Jaén-Olasolo P
Actas Dermosifiliogr; 2013 Jun; 104(5):393-9. PubMed ID: 23664412
[TBL] [Abstract][Full Text] [Related]
27. Unilesional plantar mycosis fungoides treated with topical photodynamic therapy - case report and review of the literature.
Kaufmann F; Kettelhack N; Hilty N; Kempf W
J Eur Acad Dermatol Venereol; 2017 Oct; 31(10):1633-1637. PubMed ID: 28168737
[TBL] [Abstract][Full Text] [Related]
28. Mycosis fungoides in pediatric patients: Clinical features, diagnostic challenges, and advances in therapeutic management.
Wu JH; Cohen BA; Sweren RJ
Pediatr Dermatol; 2020 Jan; 37(1):18-28. PubMed ID: 31630432
[TBL] [Abstract][Full Text] [Related]
29. Blue light photodynamic therapy with 5-aminolevulinic acid in refractory mycosis fungoides: A prospective, open-label study.
Severson KJ; Cumsky HJL; Brumfiel CM; Janeczek MC; Ginos BF; Kosiorek HE; Besch-Stokes J; Patel MH; Rule WG; DiCaudo DJ; Rosenthal AC; Pittelkow MR; Mangold AR
J Am Acad Dermatol; 2021 Oct; 85(4):969-971. PubMed ID: 33493572
[No Abstract] [Full Text] [Related]
30. Photo-photochemotherapy in Juvenile-onset Mycosis Fungoides: A Retrospective Study on 9 Patients.
Brazzelli V; Bernacca C; Segal A; Barruscotti S; Bolcato V; Michelerio A; Tomasini CF
J Pediatr Hematol Oncol; 2019 Jan; 41(1):34-37. PubMed ID: 30130275
[TBL] [Abstract][Full Text] [Related]
31. A case of photocontact urticaria induced by photodynamic therapy with topical 5-aminolaevulinic acid.
Yokoyama S; Nakano H; Nishizawa A; Kaneko T; Harada K; Hanada K
J Dermatol; 2005 Oct; 32(10):843-7. PubMed ID: 16361740
[TBL] [Abstract][Full Text] [Related]
32. The effect of psoralen plus ultraviolet A in vitro in HUT-78 enhances by 5-aminolevulinic acid.
Akita Y; Watanabe D; Yanagishita T; Kuhara T; Kawamura C; Masuda Y; Kawada M; Nakaseko H; Tamada Y; Matsumoto Y
Photodermatol Photoimmunol Photomed; 2007; 23(2-3):95-7. PubMed ID: 17523931
[TBL] [Abstract][Full Text] [Related]
33. [Change of level of mycosis fungoides under systemic PUVA-therapy (author's transl)].
Tourbier H; Schultz-Ehrenburg U
Z Hautkr; 1981 Jul; 56(14):923-9. PubMed ID: 7269717
[TBL] [Abstract][Full Text] [Related]
34. Mycosis fungoides responding to photopheresis.
Oncology (Williston Park); 1989 Jul; 3(7):36. PubMed ID: 2641913
[No Abstract] [Full Text] [Related]
35. Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides): The FLASH Phase 3 Randomized Clinical Trial.
Kim EJ; Mangold AR; DeSimone JA; Wong HK; Seminario-Vidal L; Guitart J; Appel J; Geskin L; Lain E; Korman NJ; Zeitouni N; Nikbakht N; Dawes K; Akilov O; Carter J; Shinohara M; Kuzel TM; Piette W; Bhatia N; Musiek A; Pariser D; Kim YH; Elston D; Boh E; Duvic M; Huen A; Pacheco T; Zwerner JP; Lee ST; Girardi M; Querfeld C; Bohjanen K; Olsen E; Wood GS; Rumage A; Donini O; Haulenbeek A; Schaber CJ; Straube R; Pullion C; Rook AH; Poligone B
JAMA Dermatol; 2022 Sep; 158(9):1031-1039. PubMed ID: 35857290
[TBL] [Abstract][Full Text] [Related]
36. [Photodynamic therapy of cutaneous T-cell lymphoma at special sites].
Eich D; Eich HT; Otte HG; Ghilescu V; Stadler R
Hautarzt; 1999 Feb; 50(2):109-14. PubMed ID: 10097953
[TBL] [Abstract][Full Text] [Related]
37. Mycosis fungoides responding to systemic itraconazole.
Cooper SM; Sheridan A; Burge S
J Eur Acad Dermatol Venereol; 2003 Sep; 17(5):588-90. PubMed ID: 12941104
[TBL] [Abstract][Full Text] [Related]
38. Poikilodermatous mycosis fungoides.
Farley-Loftus R; Mandal R; Latkowski JA
Dermatol Online J; 2010 Nov; 16(11):8. PubMed ID: 21163159
[TBL] [Abstract][Full Text] [Related]
39. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of new tumors in the setting of stage I/IIA mycosis fungoides.
Harrington CR; Guillén DR; Pandya AG
Clin Lymphoma Myeloma; 2007 Jul; 7(7):480-5. PubMed ID: 17875239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
